Cargando…
Effect of Trandolapril on Regression of Retinopathy in Hypertensive Patients with Type 2 Diabetes: A Prespecified Analysis of the Benedict Trial
Background. The effect of angiotensin converting enzyme inhibitors (ACEi) on regression of retinopathy in type 2 diabetics is still ill defined. Methods. We compared the incidence of retinopathy regression in 90 hypertensive type 2 diabetics randomized to at least 3-year blinded ACEi with trandolapr...
Autores principales: | Ruggenenti, Piero, Iliev, Ilian, Filipponi, Marco, Tadini, Stefano, Perna, Annalisa, Ganeva, Maria, Ene-Iordache, Bogdan, Cravedi, Paolo, Trevisan, Roberto, Bossi, Antonio, Remuzzi, Giuseppe |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2901608/ https://www.ncbi.nlm.nih.gov/pubmed/20628590 http://dx.doi.org/10.1155/2010/106384 |
Ejemplares similares
-
Preventing Left Ventricular Hypertrophy by ACE Inhibition in Hypertensive Patients With Type 2 Diabetes: A prespecified analysis of the Bergamo Nephrologic Diabetes Complications Trial (BENEDICT)
por: Ruggenenti, Piero, et al.
Publicado: (2008) -
Managing hypertension in diabetic patients – focus on trandolapril/verapamil combination
por: Sharma, Sanjib Kumar, et al.
Publicado: (2007) -
Effects of Combined Ezetimibe and Simvastatin Therapy as Compared With Simvastatin Alone in Patients With Type 2 Diabetes: A prospective randomized double-blind clinical trial
por: Ruggenenti, Piero, et al.
Publicado: (2010) -
Impact of the PPAR-γ2 Pro12Ala Polymorphism and ACE Inhibitor Therapy on New-Onset Microalbuminuria in Type 2 Diabetes: Evidence From BENEDICT
por: De Cosmo, Salvatore, et al.
Publicado: (2009) -
Impact of a Complement Factor H Gene Variant on Renal Dysfunction, Cardiovascular Events, and Response to ACE Inhibitor Therapy in Type 2 Diabetes
por: Valoti, Elisabetta, et al.
Publicado: (2019)